- Home
- GNLX vs WALD Comparison
GNLX vs WALD Comparison
Compare GNLX & WALD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GNLX | WALD |
|---|---|---|
| Founded | 2001 | 1988 |
| Country | United States | United Kingdom |
| Employees | N/A | 364 |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.6M | 130.8M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | GNLX | WALD |
|---|---|---|
| Price | $2.52 | $0.83 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $17.25 | $2.00 |
| AVG Volume (30 Days) | 210.7K | ★ 272.5K |
| Earning Date | 05-05-2026 | 03-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 9.47 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,000.00 | N/A |
| Revenue This Year | N/A | $9.89 |
| Revenue Next Year | N/A | $4.31 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.26 | $0.79 |
| 52 Week High | $8.54 | $3.22 |
Technical Indicators
Market Signals| Indicator | GNLX | WALD |
|---|---|---|
| Relative Strength Index (RSI) | 44.99 | 26.81 |
| Support Level | $2.30 | N/A |
| Resistance Level | $2.97 | $2.06 |
| Average True Range (ATR) | 0.21 | 0.09 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 37.29 | 13.15 |
Price Performance
Historical ComparisonAbout GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
About WALD Waldencast plc
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.